Basics Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. IPO Date: September 11, 2017 Sector: Healthcare Industry: Biotech Market Cap: $224.54M Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 2.50% Avg Daily Range (30 D): $0.17 | 2.60% Avg Daily Range (90 D): $0.15 | 2.44% Institutional Daily Volume Avg Daily Volume: .09M Avg Daily Volume (30 D): .07M Avg Daily Volume (90 D): .07M Trade Size Avg Trade Size (Sh.): 131 Avg Trade Size (Sh.) (30 D): 85 Avg Trade Size (Sh.) (90 D): 103 Institutional Trades Total Inst.Trades: 34 Avg Inst. Trade: $2.95M Avg Inst. Trade (30 D): $.63M Avg Inst. Trade (90 D): $1.03M Avg Inst. Trade Volume: .37M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $6.7M Avg Closing Trade (30 D): $3.23M Avg Closing Trade (90 D): $3.23M Avg Closing Volume: 817.09K         News Feb 7, 2025 @ 12:00 PM Fennec Pharmaceuticals Announces Commercial Launch... Source: Fennec Pharmaceuticals Inc. Jul 1, 2024 @ 10:00 AM Fennec Pharmaceuticals Announces Management Change... Source: Fennec Pharmaceuticals Inc. Jun 25, 2024 @ 8:35 PM Fennec Announces Results of Annual Meeting Source: Fennec Pharmaceuticals Inc. May 14, 2024 @ 11:15 AM Adherex Technologies Inc. (FENC) Lags Q1 Earnings ... Source: Zacks Equity Research May 14, 2024 @ 10:03 AM Fennec Pharmaceuticals Reports First Quarter 2024 ... Source: Fennec Pharmaceuticals Inc. Financials   TTM Q4 2024 FY 2024 Basic EPS $-.04 $-.08 $-.02 Diluted EPS $-.04 $-.08 $-.02 Revenue $ 8.75M $ 7.93M $ 47.54M Gross Profit $ $ $ Net Income / Loss $ -1.17M $ -1.99M $ -.44M Operating Income / Loss $ -.81M $ -.93M $ 2.57M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio     Splits Sep 05, 2014:   1:3 Aug 30, 2011:   1:18 Aug 02, 2005:   1:5